Demand for the Treasury securities most vulnerable to inflation is climbing to an almost two-year high as pension funds and insurance companies snap up discounted debt with consumer prices rising at the slowest since 2010.
Blackstone Group LP’s Stephen Schwarzman said his firm is planning a mutual fund-type offering as the world’s biggest alternative-asset manager joins firms from Carlyle Group LP to KKR & Co. in efforts to attract individual investors.
Ralph Whitworth’s Relational Investors LLC got ball-bearings maker Timken Co. to consider spinning off its steel unit as the company hired Goldman Sachs Group Inc. to study options after stockholders backed a split.
New collateral rules for hedge funds, insurers and others in the $633 trillion over-the-counter derivatives market are poised to boost demand for U.S. Treasuries, potentially slowing rising yields as the Federal Reserve considers scaling back unprecedented stimulus.
President Barack Obama’s sitdown with Chinese President Xi Jinping this weekend comes as acquisitions by mainland companies in the U.S. heighten public unease toward its economic rival. Proponents of the deals say Americans ought to relax.
Croydon Pension Fund will double its investment with BlueCrest Capital Management LLP, the hedge-fund firm started by Michael Platt, after the British municipal pension plan pulled its money from Fauchier Partners LLP.
Lawrence Schloss, New York City's chief investment officer and deputy comptroller for pensions, says 8 percent return is possible for pension plan holders. Schloss talks with Bloomberg's Tom Keene and Sara Eisen on Bloomberg Radio's "Bloomberg Surveillance." Guest Host Meredith Whitney, analyst and chief executive officer of Meredith Whitney Advisory Group also joins the discussion. (Source: Bloomberg)
Corporate governance advocates and shareholder activists have long complained that chief executive officer pay, which has jumped by a third since 2007, is sometimes way out of line with the CEO’s on-the-job performance.
Hospitals in the U.S. pledge to keep a patient’s health background confidential. Yet states from Washington to New York are putting privacy at risk by selling records that can be used to link a person’s identity to medical conditions using public information.